Back
Akari Therapeutics PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Sell
14
AKTX
Akari Therapeutics PLC
Last Price:
$0.95
Seasonality Move:
-8.16%
Sell
20
ADAP
Adaptimmune Therapeutics PLC
Last Price:
$0.60
Seasonality Move:
36.97%
Sell
14
Akari Therapeutics PLC (AKTX)
is a Sell
Is Akari Therapeutics PLC a Buy, Sell or Hold?
-
The current Akari Therapeutics PLC [AKTX] share price is $0.97. The Score for AKTX is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
-
AKTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
20
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
-
The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.60. The Score for ADAP is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
ADAP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
AKTX Stock Price Chart
What is Akari Therapeutics PLC's stock price today?
-
The Akari Therapeutics PLC share price today is $0.97Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTX is experiencing slight selling pressure.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $0.60The current trend is relatively stagnant and ADAP is experiencing slight buying pressure.
AKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.26 | Sell |
| Relative Strength Index (14 RSI): | 31.31 | Sell |
| Chaikin Money Flow: | -13697 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.91 - 1.57) | Sell |
| Bollinger Bands (100): | (1.66 - 3.5) | Sell |
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 38.3 | Sell |
| Chaikin Money Flow: | 3030174 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.6 - 0.7) | Sell |
| Bollinger Bands (100): | (0.69 - 1.09) | Sell |
AKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.98 | Sell |
| 20-day SMA: | 1.12 | Sell |
| 50-day SMA: | 1.81 | Sell |
| 200-day SMA: | 2.42 | Sell |
| 8-day EMA: | 1.01 | Sell |
| 20-day EMA: | 1.2 | Sell |
| 50-day EMA: | 1.73 | Sell |
| 200-day EMA: | 2.59 | Sell |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.61 | Sell |
| 20-day SMA: | 0.65 | Sell |
| 50-day SMA: | 0.72 | Sell |
| 200-day SMA: | 1.04 | Sell |
| 8-day EMA: | 0.61 | Sell |
| 20-day EMA: | 0.64 | Sell |
| 50-day EMA: | 0.73 | Sell |
| 200-day EMA: | 0.93 | Sell |
Akari Therapeutics PLC Earnings Growth & AKTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and a decrease next year of $0.33 per share.
Akari Therapeutics PLC Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adaptimmune Therapeutics PLC Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||